DR. DANIEL GEALY
MDReal-Time HydratedLIFETIME INDUSTRY VALUE
$432
2021 – 2025 Cumulative
Conflict of Interest Analysis
Dr. GEALY is a verified Ophthalmology practitioner based in HOUSTON, TX.
Between 2021 and 2025, Dr. GEALY had an overall industry promotional and research financial footprint of $432 as recorded in the federal CMS Open Payments database.
- $432 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
- $0 was allocated to sponsored clinical trials and medical research activities.
Dr. GEALY's primary funding source is REGENERON HEALTHCARE SOLUTIONS, which accounts for $284 (representing 65.8% of overall industry footprint).
Data coverage: 2021 – 2025 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.
Payout Trend Over Time
General Payments
Research Funding
Top Funding Entities
Pharmaceutical & Device Manufacturers making direct payments
Rank 1
$284
65.8%Rank 2
$123
28.6%Rank 3
$24
5.6%General payments include consulting honoraria, promotional speaking fees, meals, travel, educational materials, and entertainment offsets.
PROMOTIONAL COUNT
Active
ESTIMATED COMPLIANCE RISK
Standard
Itemized Transaction Archives
Direct live query to Socrata CMS Open Payments API (Bypasses local DB)
Year:
2025
2025
2024
2023
2022
2021
Click "Load Live Logs" to query the federal Open Payments registry directly.
Frequently Asked Questions
Answers compiled using federal transparency disclosure records under the Sunshine Act.